OraSure Technologies, Inc.
OSURHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframeOraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe,. At a $287.8M market cap, OraSure Technologies, Inc. ranks as a micro-cap company within healthcare. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.
Market Cap
$287.8M
Beta
1.01
P/E (TTM)
—
P/E (Fwd)
-8.31
EPS (TTM)
$-1.05
EPS (Fwd)
$-0.50
ROE
-21.2%
ROA
-10.7%
Cash
$177.0M
Total Debt
$12.7M
Free CF
-$8.9M
52W Change
45.1%
Annual Financials
Cash vs Debt
OraSure Technologies, Inc. holds $177.0M in cash against $12.7M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow is running at -$8.9M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -21.2% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $387.5M (2022) to $115.0M (2025), a 70% decline worth watching.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for OraSure Technologies, Inc. and its sector.